Close Menu

NEW YORK - Biotech firm GeneMe announced on Thursday a partnership with lyophilization services provider Biolyph to support the of scaling up GeneMe's rapid isothermal molecular point-of-care COVID-19 assay.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.